Mark B. Meyer

85 papers receiving 5.2k citations

Mark B. Meyer's Hit Papers

Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer 2004 · 524 citations
5240+7+14Years since publication100200300400500

Peers

Mark B. Meyer
Comparison fields: 5 of 115
  • Pathology and Forensic Medicine 2.7k
  • Nephrology 423
  • Nutrition and Dietetics 739
  • Orthopedics and Sports Medicine 358
  • Genetics 972
Replace Paul N. MacDonald with:
Paul N. MacDonald United States
Guy Eelen Belgium
J.C. Birkenhäger Netherlands
Noboru Horiuchi Japan
Stavroula Kousteni United States
Matsuhiko Hayashi Japan
María Jesús Larriba Spain
Dike N. Kalu United States
Marie‐Christine de Vernejoul France
Jung‐Min Koh South Korea
Mark B. Meyer relative to Paul N. MacDonald United States Paul N. MacDonald's profile →
Citations per field
00.5×6.6×
Paul N. MacDonald · 1×
Citations per year

Countries citing papers authored by Mark B. Meyer

Since Specialization
Citations

This map shows the geographic impact of Mark B. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Meyer more than expected).

Fields of papers citing papers by Mark B. Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Meyer. The network helps show where Mark B. Meyer may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark B. Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark B. Meyer Line = papers co-authored together Mark B. Meyer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer
Hit paper breakdown →
2004524
2 2005335
3 2010305
4 2012280
5 2014214
6 2006192
7 2011177
8 2012173
9 2017146
10 2015145
11 2016142
12 2009132
13 2010131
14 2014116
15 2013110
16 2010104
17 2014103
18 2011101
19 201189
20 201588

About Mark B. Meyer

Mark B. Meyer is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Genetics, Oncology and Endocrinology, Diabetes and Metabolism, having authored 87 papers that have together received 5.4k indexed citations. Recurring topics across this work include Vitamin D Research Studies (45 papers), Epigenetics and DNA Methylation (17 papers), Estrogen and related hormone effects (14 papers), Bone Metabolism and Diseases (14 papers), Digestive system and related health (11 papers), Vitamin C and Antioxidants Research (8 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Cytokine Signaling Pathways and Interactions (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.7k citations), Nephrology (423 citations), Nutrition and Dietetics (739 citations), Orthopedics and Sports Medicine (358 citations) and Genetics (972 citations). Mark B. Meyer has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include J. Wesley Pike, Nancy A. Benkusky, Paul D. Goetsch, Seong Min Lee, Kathleen A. Bishop, Lee A. Zella, Patricia LoRusso, Sung Tae Kim, Mary Varterasian and Melda Onal. Their work appears in journals such as The Journal of Steroid Biochemistry and Molecular Biology, Journal of Biological Chemistry, Molecular Endocrinology, Journal of Clinical Oncology and Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact